MEF2C and acute lymphoblastic leukemia: The ectopic overexpression of MEF2C (whose activity is known to be SIK controlled) in early thymocyte progenitor acute lymphoblastic leukemia promotes B-cell development and inhibits early T-cell differentiation (247).